• Sofia Ioannidou joined Andera Partners’ Andera Life Sciences team in 2009 as an Associate. She was promoted to Partner in 2019.
  • Prior to Andera Partners, Sofia was part of the Life Sciences team of L.E.K. Consulting London, from 2006 to 2008, having started her career in R&D with Boston-based Eyetech Pharmaceuticals, Inc., from 2003 to 2006.
  • Since 2009, she has actively contributed to a number of investments, trade sales and IPOs. Sofia currently serves on the board of Nouscom, Tubulis, Tricares, and Exciva and has previously served on the boards of Avalyn, LogicBio, Sanifit and PegaOne.
  • She holds a PhD in Cell Biology from Cancer Research UK and an MBiochem from the University of Oxford.
  • Sofia is a native Greek speaker and also speaks English, French and Spanish.

4 languages spoken